Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
Clinical trial NCT00450970 · TERMINATED
Trial details
- NCT number
- NCT00450970
- Sponsor
- Agennix
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-03-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.